There are many molecular signatures well-characterized in NB cellular subtype detection and risk definition, including MYCN amplification, mutations in ALK, PHOX2B, epigenetic factor such as ATRX, and TERT, and structural chromosomal changes [2,79,164]. This evidence concerns the gene MYCN and neuroblastoma.